Adjuvant pembrolizumab prolongs overall survival in renal cell carcinoma at high-risk of recurrence after nephrectomy. Can we do better than this?

被引：3
作者：
Ciccarese, Chiara [1 ]
Mollica, Veronica [2 ]
Marandino, Laura [3 ]
Palumbo, Carlotta [4 ]
Campi, Riccardo [5 ,6 ]
Amparore, Daniele [7 ]
机构：
[1] IRCCS A Gemelli Univ Polyclin Fdn, Dept Med & Surg Sci, Med Oncol Unit, Rome, Italy
[2] IRCCS Azienda Osped Univ Bologna, Med Oncol Unit, Bologna, Italy
[3] Royal Marsden NHS Fdn Trust, Med Oncol Unit, London, England
[4] Maggiore Car Hosp, Unit Urol, Novara, Italy
[5] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[6] Univ Florence, Careggi Hosp, Urol Robot Surg & Renal Transplantat Unit, Florence, Italy
[7] Univ Turin, San Luigi Gonzaga Hosp, Dept Urol, Turin, Italy
来源：
MINERVA UROLOGY AND NEPHROLOGY | 2024年 / 76卷 / 05期
关键词：
IMMUNOTHERAPY; ATEZOLIZUMAB;
D O I：
10.23736/S2724-6051.24.06114-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：540 / 544
页数：5
相关论文
共 27 条
[21]   Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial [J].
Pal, Sumanta Kumar ;
Uzzo, Robert ;
Karam, Jose Antonio ;
Master, Viraj A. ;
Donskov, Frede ;
Suarez, Cristina ;
Albiges, Laurence ;
Rini, Brian ;
Tomita, Yoshihiko ;
Kann, Ariel Galapo ;
Procopio, Giuseppe ;
Massari, Francesco ;
Zibelman, Matthew ;
Antonyan, Igor ;
Huseni, Mahrukh ;
Basu, Debasmita ;
Ci, Bo ;
Leung, William ;
Khan, Omara ;
Dubey, Sarita ;
Bex, Axel .
LANCET, 2022, 400 (10358) :1103-1116
[22]   Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations [J].
Porta, Camillo ;
Bamias, Aristotelis ;
Zakopoulou, Roubini ;
Myint, Zin W. ;
Cavasin, Nicola ;
Iacovelli, Roberto ;
Pichler, Martin ;
Kopecky, Jindrich ;
Kucharz, Jakub ;
Rizzo, Mimma ;
Galli, Luca ;
Buettner, Thomas ;
De Giorgi, Ugo ;
Kanesvaran, Ravindran ;
Fiala, Ondrej ;
Grande, Enrique ;
Zucali, Paolo A. ;
Kopp, Ray M. ;
Fornarini, Giuseppe ;
Bourlon, Maria T. ;
Scagliarini, Sarah ;
Molina-cerrillo, Javier ;
Aurilio, Gaetano ;
Matrana, Marc R. ;
Pichler, Renate ;
Cattrini, Carlo ;
Buechler, Tomas ;
Massari, Francesco ;
Mollica, Veronica ;
Seront, Emmanuel ;
Calabro, Fabio ;
Pinto, Alvaro ;
Berardi, Rossana ;
Zgura, Anca ;
Mammone, Giulia ;
Ansari, Jawaher ;
Atzori, Francesco ;
Chiari, Rita ;
Caffo, Orazio ;
Procopio, Giuseppe ;
Sunela, Kaisa ;
Bassanelli, Maria ;
Ortega, Cinzia ;
Grillone, Francesco ;
Landmesser, Johannes ;
Merler, Sara ;
Messina, Carlo ;
Kueronya, Zsofia ;
Mosca, Alessandra ;
Bhuva, Dipen .
MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (04) :460-470
[23]   The biology and treatment of oligometastatic cancer [J].
Reyes, Diane K. ;
Pienta, Kenneth J. .
ONCOTARGET, 2015, 6 (11) :8491-8524
[24]   Renal cell carcinoma with non-clear cell histologies: all the same peas in one pod? [J].
Roussel, Eduard ;
Amparore, Daniele ;
Bertolo, Riccardo ;
Erdem, Selcuk ;
Marchioni, Michele ;
Pavan, Nicola ;
Campi, Riccardo .
MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (04) :529-531
[25]   Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial [J].
Tang, Chad ;
Msaouel, Pavlos ;
Hara, Kieko ;
Choi, Haesun ;
Le, Venus ;
Shah, Amishi Y. ;
Wang, Jennifer ;
Jonasch, Eric ;
Choi, Seungtaek ;
Quynh-nhu Nguyen ;
Das, Prajnan ;
Prajapati, Surendra ;
Yu, Zhiqian ;
Khan, Khaja ;
Powell, Steven ;
Murthy, Ravi ;
Sircar, Kanishka ;
Tannir, Nizar M. .
LANCET ONCOLOGY, 2021, 22 (12) :1732-1739
[26]   Learning from clinical trials of neoadjuvant checkpoint blockade [J].
Versluis, Judith M. ;
Long, Georgina V. ;
Blank, Christian U. .
NATURE MEDICINE, 2020, 26 (04) :475-484
[27]   Adjuvant Immunotherapy for Kidney Cancer - A New Strategy with New Challenges [J].
Voss, Martin H. ;
Motzer, Robert J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (15) :1432-1433
123